148 related articles for article (PubMed ID: 16461048)
1. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
Oberman A; Prineas RJ; Larson JC; LaCroix A; Lasser NL
Am J Cardiol; 2006 Feb; 97(4):512-9. PubMed ID: 16461048
[TBL] [Abstract][Full Text] [Related]
2. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
[TBL] [Abstract][Full Text] [Related]
4. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
[TBL] [Abstract][Full Text] [Related]
5. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of left ventricular hypertrophy.
Vakili BA; Okin PM; Devereux RB
Am Heart J; 2001 Mar; 141(3):334-41. PubMed ID: 11231428
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and heart failure in women.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
9. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction.
Barrabés JA; Figueras J; Cortadellas J; Lidón RM; Ibars S
Am J Cardiol; 2009 Feb; 103(4):455-60. PubMed ID: 19195501
[TBL] [Abstract][Full Text] [Related]
11. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
da Costa W; Riera AR; Costa Fde A; Bombig MT; de Paola AA; Carvalho AC; Fonseca FH; Luna Filho B; Póvoa R
J Electrocardiol; 2008; 41(6):724-9. PubMed ID: 18954613
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E
Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
van den Hoogen JP; van Kruijsdijk MC; van Ree JW; Mokkink HG; Thien T; van Weel C
J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
[TBL] [Abstract][Full Text] [Related]
14. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study.
Niiranen TJ; Jula AM; Kantola IM; Karanko H; Reunanen A
J Hum Hypertens; 2007 Oct; 21(10):788-94. PubMed ID: 17637793
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome among postmenopausal women in Ecuador.
Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
[TBL] [Abstract][Full Text] [Related]
17. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
Smilde TD; Asselbergs FW; Hillege HL; Voors AA; Kors JA; Gansevoort RT; van Gilst WH; de Jong PE; Van Veldhuisen DJ
Am J Hypertens; 2005 Mar; 18(3):342-7. PubMed ID: 15797651
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.
Hsieh BP; Pham MX; Froelicher VF
Am Heart J; 2005 Jul; 150(1):161-7. PubMed ID: 16084164
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of left ventricular hypertrophy and associated factors in a Thai population.
Sriratanasathavorn C; Bhuripanyo K; Mahanonda N; Leowattana W; Ruangratanaamporn O; Chotinaiwattarakul C; Krittayapong R; Kangkagate C; Chaitiraphan S
J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S218-22. PubMed ID: 11194018
[TBL] [Abstract][Full Text] [Related]
20. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
